1.
Expense | 2011 | 2012 | 2013 | 2014 | 2015 |
*, adjusted for price differentials with the purchasing power parity method, taking the price of 2011 as baseline. | |||||
All cancers | |||||
Expense | 961.8 | 1,173.8 | 1,399.2 | 1,605.1 | 1,771.1 |
Adjusted expense* | 961.8 | 1,144.1 | 1,329.2 | 1,494.9 | 1,626.7 |
Esophagus cancer | |||||
Expense | 52.7 | 56.4 | 72.6 | 73.8 | 76.0 |
Adjusted expense* | 52.7 | 55.0 | 69.0 | 68.7 | 69.8 |
Stomach cancer | |||||
Expense | 77.1 | 87.1 | 101.6 | 117.8 | 125.5 |
Adjusted expense* | 77.1 | 84.9 | 96.5 | 109.7 | 115.3 |
Colon and rectum cancer | |||||
Expense | 86.3 | 103.6 | 123.0 | 151.4 | 166.1 |
Adjusted expense* | 86.3 | 101.0 | 116.8 | 141.0 | 152.6 |
Liver cancer | |||||
Expense | 49.3 | 59.4 | 67.3 | 72.7 | 81.4 |
Adjusted expense* | 49.3 | 57.9 | 63.9 | 67.7 | 74.8 |
Trachea, bronchus, lung cancer | |||||
Expense | 113.8 | 145.8 | 163.8 | 177.0 | 194.5 |
Adjusted expense* | 113.8 | 142.1 | 155.6 | 164.8 | 178.6 |
Breast cancer | |||||
Expense | 54.7 | 71.9 | 75.0 | 82.9 | 91.7 |
Adjusted expense* | 54.7 | 70.1 | 71.2 | 77.2 | 84.2 |
Cervix uteri, corpus uteri cancer | |||||
Expense | 50.3 | 64.0 | 72.1 | 82.6 | 91.8 |
Adjusted expense* | 50.3 | 62.4 | 68.5 | 76.9 | 84.3 |
Brain tumor | |||||
Expense | 10.9 | 11.9 | 15.6 | 18.2 | 20.2 |
Adjusted expense* | 10.9 | 11.6 | 14.8 | 17.0 | 18.6 |
Leukemia | |||||
Expense | 23.4 | 26.8 | 33.2 | 31.8 | 34.9 |
Adjusted expense* | 23.4 | 26.1 | 31.5 | 29.6 | 32.1 |